Zdrowie i gospodarka · 13/02/2012
FDA Clears Way for Clonidine Hydrochloride Extended-Release Tablets to be Approved via Abbreviated New Drug Applications
The FDA has determined that KAPVAY (clonidine hydrochloride) Extended-Release Tablets, 0.2 milligram, were not withdrawn from sale due to safety or effectiveness concerns, paving the way for the approval of these tablets through abbreviated new drug applications.